CKD Bio Corp.
Research CKD Bio Corp. (063160.KS) on Bullrun: market cap KRW 73.07B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker063160.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 73.07B
- Financial periodQ2 2026
- RevenueKRW 41.09B
- Net income-KRW 5.41B
- Free cash flow-KRW 749.41M
- Gross margin3.1%
Valuation Snapshot
latest market cap is KRW 73.07B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 73.07B | n/a | n/a | n/a |
About CKD Bio Corp.
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CKD Bio Corp.'s market cap?
CKD Bio Corp.'s market capitalization is KRW 73.07B.
What does CKD Bio Corp. do?
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.